Rejected
at 7:29 a.m. Mar, 15, 2024 ]
by
Ahmed7
Bulk Suggestion
Bulk ID:
gabernathy2026/03.15.24-12:10AM
Author:
gabernathy2026
Type of change:
New card to add
Rationale for change
.
Rejection reason
Bulk rejection
Current
Suggested
Sketchy Extra
Sketchy Extra
Sketchy Extra
Sketchy Extra
Text
What is the first-line pharmacotherapy for attention-deficit hyperactivity disorder (ADHD) ≥ 6 years old?
{{c1::Stimulants}}
Extra
- e.g., methylphenidate, amphetamines
- Non-stimulant treatment options include atomoxetine (no addiction risk!) and α2-agonists (e.g., guanfacine, clonidine)
- < 6 years old: first-line is CBT
- Non-stimulant treatment options include atomoxetine (no addiction risk!) and α2-agonists (e.g., guanfacine, clonidine)
- < 6 years old: first-line is CBT
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy






Sketchy 2
Empty field
Picmonic
Empty field
Pixorize


Review Clonidine & Guanfacine




Review Clonidine & Guanfacine


Physeo
.jpg)
.jpg)
Bootcamp
Watch associated Bootcamp video - Developmental Disorders : ADHD
Watch associated Bootcamp video - Substance Misuse : Amphetamines
Watch associated Bootcamp video - Substance Misuse : Amphetamines
OME
Additional Resources
One by one
Empty field
